Recent studies have associated chemerin with several inflammatory markers in obesity and type-2 diabetes [9], [10] Thus, chemerin is considered a candidate in linking inflammation to obesity-related diseases. The gene discussed is RARRES2; the disease is obesity due to melanocortin 4 receptor deficiency.